Your browser doesn't support javascript.
loading
Therapy of chronic myeloid leukaemia can benefit from the activation of stem cells: simulation studies of different treatment combinations.
Glauche, I; Horn, K; Horn, M; Thielecke, L; Essers, M A G; Trumpp, A; Roeder, I.
Affiliation
  • Glauche I; Institute for Medical Informatics and Biometry (IMB), Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Fetscherstr. 74, D-01307 Dresden, Germany. ingmar.glauche@tu-dresden.de
Br J Cancer ; 106(11): 1742-52, 2012 May 22.
Article in En | MEDLINE | ID: mdl-22538973
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Combined Chemotherapy Protocols / Models, Theoretical Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Combined Chemotherapy Protocols / Models, Theoretical Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: Country of publication: